Literature DB >> 17597385

Migration of tumor antigen-pulsed dendritic cells after mucosal administration in the human upper respiratory tract.

Shigetoshi Horiguchi1, Tomokazu Matsuoka, Yoshitaka Okamoto, Daijyu Sakurai, Kouichi Kobayashi, Hideaki Chazono, Toyoyuki Hanazawa, Yuriko Tanaka.   

Abstract

Tumor-specific peptide-pulsed dendritic cells (DC) were administered via different routes to a group of patients with head and neck cancers. The migration and homing patterns of such antigen-stimulated cells was carefully studied employing single photon emission computed tomography (SPECT). The DC administered directly into the nasal submucosa quickly migrated very rapidly to the regional neck lymph nodes in the neck. However, after inoculation of the cells into the palatine tonsils, the DCs remained close to the site of administration and did not migrate to the regional lymph nodes or to other mucosal regions. After nasal submucosal administration of the DC, tumor-antigen-specific cytotoxic T cells were detected in the ipsilaterals but not in the contra lateral lymph nodes. These results suggest that after antigen processing, the regional lymph nodes serve as inductive sites for development of mucosal immune responses and for induction of memory cells during the local immunological responses in the nasopharyngeal-associated lymphoid tissue in man.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597385     DOI: 10.1007/s10875-007-9112-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

Review 1.  Mucosal immunization with DNA vaccines.

Authors:  Philip Hobson; Christina Barnfield; Andrew Barnes; Linda S Klavinskis
Journal:  Methods       Date:  2003-11       Impact factor: 3.608

2.  Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

Authors:  Alan Coulter; Rodney Harris; Roslyn Davis; Debbie Drane; John Cox; David Ryan; Phil Sutton; Steve Rockman; Martin Pearse
Journal:  Vaccine       Date:  2003-02-14       Impact factor: 3.641

3.  Nasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responses.

Authors:  R M Carr; C M Lolachi; R G Albaran; D M Ridley; P C Montgomery; N L O'Sullivan
Journal:  Immunol Invest       Date:  1996 Sep-Nov       Impact factor: 3.657

4.  Isolation and characterization of mouse nasal-associated lymphoid tissue.

Authors:  H Asanuma; A H Thompson; T Iwasaki; Y Sato; Y Inaba; C Aizawa; T Kurata; S Tamura
Journal:  J Immunol Methods       Date:  1997-03-28       Impact factor: 2.303

5.  Trypsin activity and bile acid concentrations in the esophagus after distal gastrectomy.

Authors:  Koji Kono; Akihiro Takahashi; Hidemitsu Sugai; Hidehiko Iizuka; Hideki Fujii
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

6.  Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides.

Authors:  Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

7.  Nasal-associated lymphoid tissue (NALT): frequency and localization in young children.

Authors:  A S Debertin; T Tschernig; H Tönjes; W J Kleemann; H D Tröger; R Pabst
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

8.  Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides.

Authors:  B A Tjoa; S J Simmons; V A Bowes; H Ragde; M Rogers; A Elgamal; G M Kenny; O E Cobb; R C Ireton; M J Troychak; M L Salgaller; A L Boynton; G P Murphy
Journal:  Prostate       Date:  1998-06-15       Impact factor: 4.104

9.  Induction of compartmentalized B-cell responses in human tonsils.

Authors:  M Quiding-Järbrink; G Granström; I Nordström; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand.

Authors:  G Grouard; M C Rissoan; L Filgueira; I Durand; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more
  6 in total

1.  Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells.

Authors:  Rémi J Creusot; Shahriar S Yaghoubi; Pearl Chang; Justine Chia; Christopher H Contag; Sanjiv S Gambhir; C Garrison Fathman
Journal:  Blood       Date:  2009-04-10       Impact factor: 22.113

2.  Natural killer T cell based Immunotherapy.

Authors:  Priyanka B Subrahmanyam; Wenji Sun; James E East; Junxin Li; Tonya J Webb
Journal:  J Vaccines Vaccin       Date:  2012-08-23

3.  Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease.

Authors:  R Kobayashi; T Kobayashi; F Sakai; T Hosoya; M Yamamoto; T Kurita-Ochiai
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

Review 4.  Targeting Natural Killer T Cells in Solid Malignancies.

Authors:  Zewde Ingram; Shriya Madan; Jenoy Merchant; Zakiya Carter; Zen Gordon; Gregory Carey; Tonya J Webb
Journal:  Cells       Date:  2021-05-27       Impact factor: 6.600

5.  Immunosuppressive property of submandibular lymph nodes in patients with head and neck tumors: differential distribution of regulatory T cells.

Authors:  Daiju Sakurai; Ryosuke Uchida; Fumie Ihara; Naoki Kunii; Takuya Nakagawa; Hideaki Chazono; Toyoyuki Hanazawa; Shinichiro Motohashi; Yoshitaka Okamoto
Journal:  BMC Res Notes       Date:  2018-07-16

Review 6.  Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer.

Authors:  Mariko Takami; Fumie Ihara; Shinichiro Motohashi
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.